Participants:0–17 years · 18–64 years
Substances:Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dmpk Via A Non-Cleavable Linker

Contact Research Centre

Varicella

Recruiting

Registered drugNo placebo

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Registered drugNo placebo

Denmark

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896

Contact Research Centre

Secondary immunodeficiency

Recruiting

Registered drugNo placebo

Study of human normal immunoglobulin and teclistamab for infection prevention in adults with multiple myeloma receiving B-cell maturation antigen therapy

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Teclistamab

Contact Research Centre

Autoimmune haemolytic anaemia

Recruiting

Investigational

Study of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Rilzabrutinib

Contact Research Centre

COVID-19

Recruiting

Investigational

Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:IBUZATRELVIR

Contact Research Centre

Ovarian cancer

Recruiting

Registered drugNo placebo

Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Neovascular age-related macular degeneration+1

Recruiting

Registered drugNo placebo

Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Ranibizumab

Contact Research Centre

Transitional cell carcinoma

Recruiting

Registered drugNo placebo

Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Evaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Chronic kidney disease

Recruiting

Registered drugNo placebo

Study of semaglutide and finerenone for kidney and blood vessel protection in adults with chronic kidney disease, with or without diabetes

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Finerenone

Contact Research Centre

Type 1 diabetes mellitus+1

Recruiting

Registered drugNo placebo

Study of semaglutide for weight loss in adults with type 1 diabetes and obesity

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Placebo

Contact Research Centre

Find therapies in clinical trials near you – page 8

630 trials match your criteria

Primary mediastinal large B-cell lymphoma+3

Study of dapagliflozin to prevent heart complications during lymphoma treatment in patients receiving first-line therapy

Myotonic dystrophy

Study of intravenous AOC 1001 to evaluate long-term safety and effectiveness in patients with myotonic dystrophy type 1

Varicella

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Secondary immunodeficiency

Study of human normal immunoglobulin and teclistamab for infection prevention in adults with multiple myeloma receiving B-cell maturation antigen therapy

Autoimmune haemolytic anaemia

Study of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia

COVID-19

Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

Ovarian cancer

Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

Neovascular age-related macular degeneration+1

Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

Transitional cell carcinoma

Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Triple negative breast cancer

Evaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression

Chronic kidney disease

Study of semaglutide and finerenone for kidney and blood vessel protection in adults with chronic kidney disease, with or without diabetes

Type 1 diabetes mellitus+1

Study of semaglutide for weight loss in adults with type 1 diabetes and obesity

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.